[{"arm_notes": "", "treatment_id": null, "treatment_name": "TODO N/AControl group: This group is not face to special intervention and is examined in parallel with the case group in terms of memory indexes.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - DrugsIntervention group: This group is treated with Donepezil Hydrochloride with the brand name Aricept at a dose of 5 mg (half a tablet for the first 5 nights and then one tablet overnight for 3 months and from 3 months to 6 months after starting the drug are reached the dose10 mg daily). This drug is FDA-APPROVED for the treatment of Alzheimer's disease and is currently routinely prescribed in Iran.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 1826, "treatment_name": "Donepezil", "treatment_type": "Central nervous system agents", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]